RECORDATI: L’ASSEMBLEA APPROVA IL BILANCIO DEL 2019. DIVIDENDO DI € 1,00 PER OGNI AZIONE (+8,7% vs 2018)
April 29, 2020 06:19 ET
|
RECORDATI
RECORDATI: L’ASSEMBLEA APPROVA IL BILANCIO DEL 2019. DIVIDENDO DI € 1,00 PER OGNI AZIONE (+8,7% vs 2018). L’Assemblea approva il bilancio 2019: ricavi netti consolidati € 1.481.8 milioni (+9,6% vs...
RECORDATI SHAREHOLDERS APPROVE THE 2019 ACCOUNTS. DIVIDEND € 1.00 PER SHARE (+8.7% vs 2018)
April 29, 2020 06:19 ET
|
RECORDATI
RECORDATI SHAREHOLDERS APPROVE THE 2019 ACCOUNTS. DIVIDEND € 1.00 PER SHARE (+8.7% vs 2018). Shareholders approve the 2019 results: consolidated revenues € 1,481.8 million (+9.6% vs 2018), EBITDA...
Recordati Rare Diseases now holds Isturisa® European MA
April 08, 2020 07:01 ET
|
RECORDATI
Recordati Rare Diseases is now the European Marketing Authorization holder of Isturisa® (osilodrostat) indicated for Adult patients with Endogenous Cushing’s Syndrome Paris, 8 April, 2020 –...
RECORDATI PRESENTA RICHIESTA PER LA COMMERCIALIZZAZIONE DI ISTURISA® IN GIAPPONE
March 26, 2020 09:15 ET
|
RECORDATI
RECORDATI PRESENTA RICHIESTA PER LA COMMERCIALIZZAZIONE DI ISTURISA® IN GIAPPONE Milano, 26 marzo 2020 – Recordati annuncia la presentazione al Ministero della Sanità, Lavoro e Welfare giapponese...
RECORDATI SUBMITS NEW DRUG APPLICATION FOR ISTURISA® IN JAPAN
March 26, 2020 09:15 ET
|
RECORDATI
RECORDATI SUBMITS NEW DRUG APPLICATION FOR ISTURISA® IN JAPAN Milan, 26 March 2020 – Recordati announces the submission of the Japanese New Drug Application (JNDA) to the Ministry of Health, Labour...
RECORDATI CONTRIBUISCE AL SOSTEGNO DI STRUTTURE SANITARIE E PAZIENTI PER AFFRONTARE L’EMERGENZA EPIDEMIOLOGICA DA VIRUS COVID-19
March 18, 2020 09:42 ET
|
RECORDATI
RECORDATI CONTRIBUISCE AL SOSTEGNO DI STRUTTURE SANITARIE E PAZIENTI PER AFFRONTARE L’EMERGENZA EPIDEMIOLOGICA DA VIRUS COVID-19 Milano, 18 marzo 2020 – Recordati informa che il Gruppo ha stanziato €...
RECORDATI CONTRIBUTES TO SUPPORT HOSPITALS AND PATIENTS IN THE FACE OF THE EPIDEMIOLOGIC EMERGENCY DUE TO COVID-19
March 18, 2020 09:42 ET
|
RECORDATI
RECORDATI CONTRIBUTES TO SUPPORT HOSPITALS AND PATIENTS IN THE FACE OF THE EPIDEMIOLOGIC EMERGENCY DUE TO COVID-19 Milan, 18 March 2020 – Recordati announces that the Group has allocated € 5 million...
RECORDATI: CDA APPROVA IL BILANCIO DEL 2019. RICAVI DI € 1.481,8 MILIONI (+9,6%), EBITDA DI € 544,0 (+9,0%). DIVIDENDO 2019 € 1,00 (+8,7%).
March 18, 2020 09:22 ET
|
RECORDATI
RECORDATI: CDA APPROVA IL BILANCIO DEL 2019. RICAVI DI € 1.481,8 MILIONI (+9,6%), EBITDA DI € 544,0 (+9,0%). DIVIDENDO 2019 € 1,00 (+8,7%). Ricavi netti consolidati € 1.481.8 milioni, +9,6%.EBITDA...
BOARD APPROVES THE 2019 ACCOUNTS. SALES € 1,481.8 MILLION (+9.6%), EBITDA € 544.0 MILLION (+9.0%). 2019 DIVIDEND € 1.00 (+8.7%)
March 18, 2020 09:22 ET
|
RECORDATI
BOARD APPROVES THE 2019 ACCOUNTS. SALES € 1,481.8 MILLION (+9.6%), EBITDA € 544.0 MILLION (+9.0%). 2019 DIVIDEND € 1.00 (+8.7%). Consolidated revenues € 1,481.8 million, +9.6%.EBITDA (1) € 544.0...
RECORDATI: PRELIMINARY 2019 RESULTS CONFIRM CONTINUED GROWTH OF SALES AND PROFITS. SALES +9.6%. EBITDA +9.0%
February 14, 2020 08:11 ET
|
RECORDATI
RECORDATI: PRELIMINARY 2019 RESULTS CONFIRM CONTINUED GROWTH OF SALES AND PROFITS. SALES +9.6%. EBITDA +9.0%. Consolidated revenues € 1,481.8 million, +9.6%.EBITDA (1) € 544.0 million,...